Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway

Journal of Cellular Physiology

Volumn 223, Issue 3, 2010, Pages 798-809

  Sun, Zhong ^a   Cheng, Zhenyu ^a   Taylor, Catherine A ^a   Mcconkey, Brendan J ^a   Thompson, John E ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CASPASE; CYTOCHROME C; EUKARYOTIC TRANSLATION INITIATION FACTOR 5A1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; INITIATION FACTOR; INITIATION FACTOR 5A; MEMBRANE PROTEIN; ONCOPROTEIN; RNA BINDING PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEOMICS; TRANSLATION INITIATION; UPREGULATION; ADENOVIRUS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN TRANSPORT; SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOVIRIDAE; EUKARYOTA;

ADENOVIRIDAE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; ENZYME ACTIVATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MITOCHONDRIA; PEPTIDE INITIATION FACTORS; PROTEIN TRANSPORT; PROTEOMICS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 77951215536     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22100     Document Type: Article

References (83)

1. Antonsson B, Montessuit S, Sanchez B, Martinou JC. 2001. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615-11623. (Pubitemid 37385313)
2. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
3. Benne R, Brown-Luedi ML, Hershey JW. 1978. Purification and characterization of protein synthesis initiation factors eIF-1, eIF-4C, eIF-4D, and eIF-5 from rabbit reticulocytes. J Biol Chem 253:3070-3077.
4. Blaser C, Kaufmann M, Müller C, Zimmermann C, Wells V, Mallucci L, Pircher H. 1998. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 28:2311-2319. (Pubitemid 28362706)
5. Brachat A, Pierrat B, Xynos A, Brecht K, Simonen M, Brüngger A, Heim J. 2002. Amicroarray-based, integrated approach to identify novel regulators of cancer drug response and apoptosis. Oncogene 21:8361-8371. (Pubitemid 35477878)
6. Brockstedt E, Otto A, Rickers A, Bommert K, Wittmann-Liebold B. 1999. Preparative high-resolution two-dimensional electrophoresis enables the identification of RNApolymerase B transcription factor 3 as an apoptosis-associated protein in the human BL 60-2. Burkitt lymphoma cell line. J Protein Chem 18:225-231. (Pubitemid 29217948)
7. Byers TL, Lakanen JR, Coward JK, Pegg AE. 1994. The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: New evidence provided by 1-methylspermidine and 1,12- dimethylspermine. Biochem J 303:363-368.
8. Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Baldi A, Tassone P, Venuta S, Tagliaferri P, Abbruzzese A. 2003. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (Tokyo) 133:757-765. (Pubitemid 36898647)
9. Chatterjee I, Gross SR, Kinzy TG, Chen KY. 2006. Rapid depletion of mutant eukaryotic initiation factor 5A at restrictive temperature reveals connections to actin cytoskeleton and cell cycle progression. Mol Genet Genomics 275:264-276. (Pubitemid 43357663)
10. Cheng Z, Wei Y-YC, Sung WW, Glick BR, McConkey BJ. 2009. Proteomic analysis of the response of the plant growth-promoting bacterium Pseudomonas putida UW4 to nickel stress. Proteome Sci 7:18.
11. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, Li P. 2003. Mitochondrial translocation of cofilin is an early step in apoptosis induction. Nat Cell Biol 5:1083-1089. (Pubitemid 37509115)
12. Cleary ML, Smith SD, Sklar J. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28. (Pubitemid 17181529)
13. Clement PM, Henderson CA, Jenkins ZA, Smit-McBride Z, Wolff EC, Hershey JW, Park MH, Johansson JE. 2003. Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem 270:4254-4263. (Pubitemid 37340343)
14. Clement PM, Johansson HE, Wolff EC, Park MH. 2006. Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J 273:1102-1114. (Pubitemid 43345032)
15. Cooper HL, Park MH, Folk JE, Safer B, Braverman R. 1982. Posttranslational formation of hypusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth. Cell 29:791-797.
16. Cracchiolo BM, Heller DS, Clement PMJ, Wolff EC, Park M-H, Hanauske-Abel HM. 2004. Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol Oncol 94:217-222.
17. Drexler H. 1997. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 94:855-860.
18. Elmore S. 2007. Apoptosis: A review of programmed cell death. Toxicol Pathol 35:495-516. (Pubitemid 46911891)
19. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G, Lazebnik YA. 1998. Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci USA 95:13664-13669.
20. Garneau D, Revil T, Fisette J-F, Chabot B. 2005. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem 280:22641-22650. (Pubitemid 40853168)
21. Gomez-Bougie P, Bataille R, Amiot M. 2004. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells. Eur J Immunol 34:3156-3164. (Pubitemid 39549394)
22. Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM. 2001. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 61:3806-3809.
23. Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y, Sham JS. 2004. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 64:4197-4200.
24. Han J, Goldstein LA, Gastman BR, Rabinowich H. 2006. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 281:10153-10163.
25. Hanauske-Abel HM, Park MH, Hanauske AR, Popowicz AM, Lalande M, Folk JE. 1994. Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta 1221:115-124.
26. Harrington EA, Fanidi A, Evan GI. 1994. Oncogenes and cell death. Curr Opin Genet Dev 4:120-129.
27. Harris MH, Thompson CB. 2000. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 7:1182-1191.
28. He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R. 2005. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci 118:3173-3183.
29. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:770-776.
30. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
31. Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC. 2001. Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol 152:895-910.
32. Jao DL, Chen KY. 2006. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex. J Cell Biochem 97:583-598.
33. Jenkins ZA, Hååg PG, Johansson HE. 2001. Human EIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 71:101-109.
34. Jin BF, He K, Wang HX, Wang J, Zhou T, Lan Y, Hu MR, Wei KH, Yang SC, Shen BF, Zhang XM. 2003. Proteomic analysis of ubiquitin-proteasome effects: Insight into the function of eukaryotic initiation factor 5A. Oncogene. 22:4819-4830.
35. Jin S, Taylor CA, Liu Z, Sun Z, Ye B, Thompson JE. 2008. Suppression of primary and disseminated murine tumor growth with eIF5A1 gene therapy. Gene Ther Mol Biol 12:207-218.
36. Jost CA, Marin MC, Kaelin WG, Jr. 1997. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389:191-194.
37. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95:4997-5002.
38. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
39. Kang HA, Hershey JW. 1994. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 269:3934-3940.
40. Klier H, Csonga R, Joäo HC, Eckerskorn C, Auer M, Lottspeich F, Eder J. 1995. Isolation and structural characterization of different isoforms of the hypusine-containing protein eIF-5A from HeLa cells. Biochemistry 34:14693-14702.
41. Ko HS, Uehara T, Nomura Y. 2002. Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J Biol Chem 277:35386-35392.
42. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and d ATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
43. Li AL, Li HY, Jin BF, Ye QN, Zhou T, Yu XD, Pan X, Man JH, He K, Yu M, Hu MR, Wang J, Yang SC, Shen BF, Zhang XM. 2004. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 279:49251-49258.
44. MacLaren AP, Chapman RS, Wyllie AH, Watson CJ. 2001. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ 8:210-218.
45. Marchet A, Mocellin S, Belluco C, Ambrosi A, De Marchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M, Nitti D. 2007. Gene expression profile of primary gastric cancer: Towards the prediction of lymph node status. Ann Surg Oncol 14:1058-1064.
46. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin WG, Jr. 1998. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol 18:6316-6324.
47. Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M, Knight RA, Green DR, Thompson C, Vousden KH. 2004. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083.
48. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC. 1998. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17:384-395.
49. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. 2001. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108:223-232.
50. Park MH, Cooper HL, Folk JE. 1982. The biosynthesis of protein-bound hypusine (N epsilon-(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor and the intermediate role of deoxyhypusine (N epsilon-(4-aminobutyl) lysine). J Biol Chem 257:7217-7222.
51. Park MH, Wolff EC, Abbruzzese A, Folk JE. 1988. Post-translational formation of hypusine: Biogenesis of translation initiation factor eIF-4D. Adv Exp Med Biol 231:633-640.
52. Park MH, Wolff EC, Folk JE. 1993a. Hypusine: Its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 4:95-104.
53. Park MH, Wolff EC, Lee YB, Folk JE. 1993b. Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem 269:27827-27832.
54. Park MH, Joe YA, Kang KR. 1998. Deoxyhypusine synthase activity is essential for cell viability in the yeast Saccharomyces cerevisiae. J Biol Chem 273:1677-1683.
55. Park J-H, Aravind L, Wolff EC, Kaevel J, Kim YS, Park MH. 2006. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: A HEAT-repeat-containing metalloenzyme. Proc Natl Acad Sci USA 103:51-56.
56. Patry C, Bouchard L, Labrecque P, Gendron D, Lemieux B, Toutant J, Lapointe E, Wellinger R, Chabot B. 2003. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res 63:7679-7688.
57. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. 1995. Apoptosis of T cells mediated by galectin-1. Nature 378:736-739.
58. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551-3567.
59. Peter ME, Krammer PH. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26-35.
60. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML. 1995. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130:157-167.
61. Ramaswamy S, Ross KN, Lander ES, Golub TR. 2003. A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54.
62. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. 1990. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-75559.
63. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA. 1998. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17:3401-3415.
64. Saini P, Eyler DE, Green R, Dever TE. 2009. Hypusine-containing protein eIF5A promotes translation elongation. Nature 459:118-121.
65. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
66. Scheffner M, Munger K, Byrne JC, Howley PM. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527.
67. Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C. 2004. Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol 164:1021-1032.
68. Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JW. 1991. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol 11:3105-3114.
69. Shimizu S, Narita M, Tsujimoto Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399:483-487.
70. Smit-McBride Z, Dever TE, Hershey JW, Merrick WC. 1989. Sequence determination and cDNA cloning of eukaryotic initiation factor 4D, the hypusine-containing protein. J Biol Chem 264:1578-1583. (Pubitemid 19050997)
71. Sunters A, Fernández deMattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW. 2003. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278:49795-49805.
72. Taylor CA, Senchyna M, Flanagan J, Joyce EM, Cliche DO, Boone AN, Culp-Stewart S, Thompson JE. 2004. Role of eIF5A in TNF-alpha-mediated apoptosis of lamina cribrosa cells. Invest Ophthalmol Vis Sci 45:3568-3576. (Pubitemid 39298575)
73. Taylor CA, Sun Z, Cliche DO, Ming H, Eshaque B, Jin S, Hopkins MT, Thai B, Thompson JE. 2007. Eukaryotic translation initiation factor 5Ainduces apoptosis in colon cancer cells and associateswith the nucleus in response to tumour necrosis factor alpha signalling. Exp Cell Res 313:437-449. (Pubitemid 46186299)
74. Thiede B, Dimmler C, Siejak F, Rudel T. 2001. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J Biol Chem 276:26044-26050. (Pubitemid 37412813)
75. Thomas M, Matlashewski G, Pim D, Banks L. 1996. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene 2:265-273. (Pubitemid 26334858)
76. Valentini SR, Casolari JM, Oliveira CC, Silver PA, McBride AE. 2002. Genetic interactions of yeast eukaryotic translation initiation factor 5A (eIF5A) reveal connections to poly(A)-binding protein and protein kinase C signaling. Genetics 160:393-405.
77. Wang X, Sun H, Li C. 2007. Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway. Leuk Res 31:653-660. (Pubitemid 46560000)
78. Weir BA, Yaffe MP. 2004. Mmd1p, a novel, conserved protein essential for normal mitochondrial morphology and distribution in the fission yeast Schizosaccharomyces pombe. Mol Biol Cell 15:1656-1665.
79. Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY. 2008. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 39:80-86. (Pubitemid 350216163)
80. Zamzami N, Kroemer G. 2001. The mitochondrion in apoptosis: How Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71. (Pubitemid 33676964)
81. Zanelli CF, Valentini SR. 2005. Pkc1 acts through Zds1 and Gic1 to suppress growth and cell polarity defects of a yeast eIF5A mutant. Genetics 171:1571-1581.
82. Zanelli CF, Maragno AL, Gregio AP, Komili S, Pandolfi JR, Mestriner CA, Lustri WR, Valentini SR. 2006. eIF5A binds to translational machinery components and affects translation in yeast. Biochem Biophys Res Commun 348:1358-1366. (Pubitemid 44291350)
83. Zuk D, Jacobson A. 1998. A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J 17:2914-2925. (Pubitemid 28227138)